Editor's letter: A shot in the arm?

One sudden event can have a positive impact

Lauren Mason
clock • 3 min read

8 November marks the one-year anniversary of ‘Pfizer Monday’ – when stockmarkets surged following the news that Pfizer and BioNTech’s coronavirus vaccine was 90% effective in trials.

The increased likelihood that life would once again return to normal caused the MSCI All-Country World index to surpass its previous record high, while the FTSE 100 saw its biggest single-day jump since before the pandemic.  It was after this that the ‘growth-versus-value' debate reared its head, with sectors that were particularly hard hit by Covid, as well as cyclical stocks, experiencing rapid rebounds. In an IW article published less than a week after the Pfizer announcement, Antipodes Partners' client portfolio manager Alison Savas said investors who "continue pouring into growth...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Markets

Over £900m lost in UK finance and insurance private investment in 2024

Over £900m lost in UK finance and insurance private investment in 2024

Fourth largest percentage decrease across sectors

Patrick Brusnahan
clock 10 July 2025 • 1 min read
Wellington Management's Natasha Brook-Walters: How to position for the new investing regime

Wellington Management's Natasha Brook-Walters: How to position for the new investing regime

Time to evolve

Natasha Brook-Walters
clock 10 July 2025 • 4 min read
Global IPOs expected to 'remain quiet' amid market volatility triggered by Trump's tariffs

Global IPOs expected to 'remain quiet' amid market volatility triggered by Trump's tariffs

European and UK IPOs on decline

Sorin Dojan
clock 09 July 2025 • 2 min read
Trustpilot